- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x FE2: FE (II) ION(Non-covalent)
- 6 x ZR5: N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide(Non-covalent)
ZR5.2: 15 residues within 4Å:- Chain A: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.3
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:I.419, A:I.419, A:L.595, A:L.595, A:A.598, A:I.599
- Hydrogen bonds: A:L.184, A:R.195, A:R.296, A:R.591
ZR5.5: 15 residues within 4Å:- Chain B: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.6
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:I.419, B:I.419, B:L.595, B:L.595, B:A.598, B:I.599
- Hydrogen bonds: B:L.184, B:R.195, B:R.296, B:R.591
ZR5.8: 15 residues within 4Å:- Chain C: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.9
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:I.419, C:I.419, C:L.595, C:L.595, C:A.598, C:I.599
- Hydrogen bonds: C:L.184, C:R.195, C:R.296, C:R.591
ZR5.11: 15 residues within 4Å:- Chain D: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.12
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:I.419, D:I.419, D:L.595, D:L.595, D:A.598, D:I.599
- Hydrogen bonds: D:L.184, D:R.195, D:R.296, D:R.591
ZR5.14: 15 residues within 4Å:- Chain E: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.15
10 PLIP interactions:10 interactions with chain E- Hydrophobic interactions: E:I.419, E:I.419, E:L.595, E:L.595, E:A.598, E:I.599
- Hydrogen bonds: E:L.184, E:R.195, E:R.296, E:R.591
ZR5.17: 15 residues within 4Å:- Chain F: T.183, L.184, G.187, A.188, M.191, R.195, R.296, I.419, K.422, R.591, L.595, A.598, I.599, H.602
- Ligands: ACD.18
10 PLIP interactions:10 interactions with chain F- Hydrophobic interactions: F:I.419, F:I.419, F:L.595, F:L.595, F:A.598, F:I.599
- Hydrogen bonds: F:L.184, F:R.195, F:R.296, F:R.591
- 6 x ACD: ARACHIDONIC ACID(Non-covalent)
ACD.3: 19 residues within 4Å:- Chain A: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.2
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:F.358, A:E.362, A:E.362, A:L.367, A:L.367, A:I.405, A:A.409, A:L.413, A:I.419, A:F.420, A:I.599, A:L.603
ACD.6: 19 residues within 4Å:- Chain B: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.5
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:F.358, B:E.362, B:E.362, B:L.367, B:L.367, B:I.405, B:A.409, B:L.413, B:I.419, B:F.420, B:I.599, B:L.603
- Salt bridges: B:H.602
ACD.9: 19 residues within 4Å:- Chain C: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.8
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:F.358, C:E.362, C:E.362, C:L.367, C:L.367, C:I.405, C:A.409, C:L.413, C:I.419, C:F.420, C:I.599, C:L.603
- Salt bridges: C:H.602
ACD.12: 19 residues within 4Å:- Chain D: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.11
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:F.358, D:E.362, D:E.362, D:L.367, D:L.367, D:I.405, D:A.409, D:L.413, D:I.419, D:F.420, D:I.599, D:L.603
ACD.15: 19 residues within 4Å:- Chain E: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.14
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:F.358, E:E.362, E:E.362, E:L.367, E:L.367, E:I.405, E:A.409, E:L.413, E:I.419, E:F.420, E:I.599, E:L.603
- Salt bridges: E:H.602
ACD.18: 19 residues within 4Å:- Chain F: F.180, F.358, E.362, H.366, L.367, H.371, I.405, R.408, A.409, L.413, I.419, F.420, Q.553, I.599, S.600, H.602, L.603, I.669
- Ligands: ZR5.17
13 PLIP interactions:13 interactions with chain F- Hydrophobic interactions: F:F.358, F:E.362, F:E.362, F:L.367, F:L.367, F:I.405, F:A.409, F:L.413, F:I.419, F:F.420, F:I.599, F:L.603
- Salt bridges: F:H.602
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mobbs, J.I. et al., Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors. Blood (2023)
- Release Date
- 2023-08-09
- Peptides
- Polyunsaturated fatty acid lipoxygenase ALOX12: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x FE2: FE (II) ION(Non-covalent)
- 6 x ZR5: N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide(Non-covalent)
- 6 x ACD: ARACHIDONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mobbs, J.I. et al., Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors. Blood (2023)
- Release Date
- 2023-08-09
- Peptides
- Polyunsaturated fatty acid lipoxygenase ALOX12: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F